| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.46B | -46.1% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.08B | — |
| Net income | ¥0.07B | -82.7% |
| Gross margin | 19.1% | Net margin 14.6% |
| Revenue Q/Q | +16.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.37B | 80.9% |
| R&D | ¥0.00B | 0.7% |
| SG&A | ¥0.01B | 1.9% |
| Tax & other | ¥0.01B | 2.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
透景生命 ・ 万通智控 ・ 南京聚隆 ・ 正元智慧 ・ 超频三 ・ 星云股份 ・ 杭州园林 ・ 太龙股份 ・ 金陵体育 ・ 雷迪克 ・ 正海生物 ・ 世纪天鸿
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies